StockWatch
·

Akebia Therapeutics, Inc.

Ticker: 1517022

P/L Snapshot

Q3 FY26 · consolidated

vs Q2 FY26·vs Q3 FY25
Revenue
36.90
-24.9%-37.2%
Expenditure
48.37
-12.8%-11.0%
Net Profit
-14.35
-61.1%-2757.4%
OPM %
-31.06%
-18.18pp-38.63pp

Shareholding

Pattern breakdown

P/L Trends

(in millions)

RevenueExpenditureNet Profit
-29.94-4.3621.2146.7972.37Q3 FY23Q1 FY24Q2 FY24Q3 FY24Q1 FY25Q2 FY25Q3 FY25Q1 FY26Q2 FY26Q3 FY26
Price Chart
Latest News